Abstract
To review the recent evidence of the effectiveness of statin therapy in the primary prevention of cardiovascular disease in men and women without established cardiovascular disease (CVD). The use of statins in patients without established CVD has important public health implications. Until recently, research has provided ambiguous answers and the reliability of treatment in older people (>65 years), women, and patients with diabetes has remained uncertain, mainly because of a lack of data or inconsistent findings within these clinically defined groups. The Justification for the use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) demonstrated a significant benefit of rosuvastatin in low-risk patients with no apparent vascular disease, low-density lipoprotein levels of less than 3.4 mmol/l, and elevated high sensitivity C-reactive protein. The latest meta-analysis of statins in 70 000 patients without established CVD confirmed the overall benefit of statins in these low-risk patients and found no significant heterogeneity of the treatment effect in the clinically defined subgroups of elderly (>65 years), women, and patients with diabetes. The use of statins in low-risk patients without CV...Continue Reading
References
Nov 16, 1995·The New England Journal of Medicine·J ShepherdC J Packard
Oct 15, 1994·Lancet·J E PedersenA Banning
Jun 5, 1998·JAMA : the Journal of the American Medical Association·J R DownsA M Gotto
May 23, 2001·JAMA : the Journal of the American Medical Association·UNKNOWN Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
Nov 30, 2002·Lancet·James ShepherdUNKNOWN PROSPER study group. PROspective Study of Pravastatin in the Elderly at Risk
Dec 20, 2002·JAMA : the Journal of the American Medical Association·UNKNOWN ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatm
Apr 11, 2003·Lancet·Peter S SeverUNKNOWN ASCOT investigators
Jun 20, 2003·Lancet·Rory CollinsUNKNOWN Heart Protection Study Collaborative Group
Jun 28, 2003·BMJ : British Medical Journal·M R LawA R Rudnicka
Jul 14, 2004·Circulation·Scott M GrundyUNKNOWN American Heart Association
Aug 25, 2004·Lancet·Helen M ColhounUNKNOWN CARDS investigators
Mar 26, 2005·BMJ : British Medical Journal·Li WeiThomas M MacDonald
Oct 11, 2005·Lancet·C BaigentUNKNOWN Cholesterol Treatment Trialists' (CTT) Collaborators
Feb 8, 2006·Circulation·Donald M Lloyd-JonesDaniel Levy
Jun 28, 2006·Diabetes Care·Robert H KnoppStuart J Pocock
Oct 3, 2006·Lancet·Haruo NakamuraUNKNOWN MEGA Study Group
Aug 30, 2007·European Heart Journal·Ian GrahamUNKNOWN European Society of Cardiology (ESC) Committee for Practice Guidelines (CPG)
Feb 27, 2008·BMJ : British Medical Journal·Giovanni F M StrippoliJonathan C Craig
Nov 11, 2008·The New England Journal of Medicine·Paul M RidkerUNKNOWN JUPITER Study Group
Feb 18, 2009·Annals of Internal Medicine·Mark J PletcherLee Goldman
Jun 2, 2009·Lancet·UNKNOWN Antithrombotic Trialists' (ATT) CollaborationAlberto Zanchetti
Mar 4, 2010·JAMA : the Journal of the American Medical Association·F Gerald R FowkesUNKNOWN Aspirin for Asymptomatic Atherosclerosis Trialists
Citations
Apr 17, 2013·European Journal of Clinical Pharmacology·Helle Wallach-KildemoesTheis Lange
Aug 7, 2012·BMC Public Health·Helle Wallach-KildemoesMorten Andersen
Jul 26, 2012·BMC Research Notes·Aaron P Mitchell, Ross J Simpson
Nov 8, 2013·Heart and Vessels·Andrea RossiCorrado Vassanelli
Nov 11, 2010·Current Cardiology Reports·Ilan GottliebCarlos Eduardo Rochitte
Sep 15, 2012·Health Policy·Helle Wallach KildemoesMorten Andersen
Jun 28, 2011·Cytokine & Growth Factor Reviews·Sze Ma, Christopher Cheng-Hwa Ma
Oct 9, 2015·Journal of Evaluation in Clinical Practice·Helle Wallach-KildemoesHálfdán Pétursson
Mar 6, 2012·The American Journal of Medicine·C Michael MinderRoger S Blumenthal
Apr 1, 2016·BMJ Open·Federico VancheriBjörn Wettermark
Mar 1, 2013·European Journal of Preventive Cardiology·Huseyin NaciA E Ades
Apr 5, 2018·Cardiorenal Medicine·Haroon KamranSamy I McFarlane
Jun 6, 2013·Nature Reviews. Cardiology·Željko Reiner